ADVERTISEMENT
Press release content from Business Wire. The AP news staff was not involved in its creation.
PRESS RELEASE: Paid content from Business Wire
Press release content from Business Wire. The AP news staff was not involved in its creation.

The CGM Market in Europe 2018-2024: Market is Expected to Exceed $800 Million by the End of 2024 - ResearchAndMarkets.com

July 16, 2018 GMT

DUBLIN--(BUSINESS WIRE)--Jul 16, 2018--The “Europe CGM Market, Users, Reimbursement Policy, Continuous Glucose Monitoring Components (Glucose Sensor, Transmitter), Diabetes (Type 1 & 2) Population, & Forecast” report has been added to ResearchAndMarkets.com’s offering.

Europe CGM Market is expected to surpass US$ 800 Million by the end of the year 2024.

Good healthcare infrastructure, rising healthcare expenditure and awareness of patients regarding CGM technology in Europe will further accelerate the market of Continuous Glucose Monitoring (CGM) device.

Key Highlights

  • Germany & France CGM Market will remain a dominant force in the European Region
  • European Countries Reimbursement Policies on CGM Device

This report studies the market from 3 view points:

ADVERTISEMENT

  • CGM Market
  • CGM Users
  • CGM Reimbursements Policy

Scope

  • CGM Market & Forecast: We have defined the CGM market of 6 countries. Market data from 2010 to 2017 and Forecast from 2018 to 2024
  • CGM Users & Forecast: We have defined CGM number of Users of 6 countries. Market data from 2010 to 2017 and Forecast from 2018 to 2024
  • Reimbursement Policy: Report provides Reimbursement Policy on CGM for 6 countries individually along with global CGM (Continuous Glucose Monitoring) reimbursement model
  • Diabetes Population: Report covers 6 Countries Type 1 and Type 2 Diabetes Population Numbers and Forecast
  • Growth Factors for CGM: This topic studies the factor which is helping the CGM industry to grow.
  • Challenges for CGM: This industry shows the problems being faced by the CGM technology

Key Topics Covered

1. Executive Summary

2. Europe - CGM User (2010 - 2024)

3. Europe - CGM Market & Forecast (2010 - 2024)

4. By Components - CGM Market (2010 - 2024)

5. Market Share - By Countries

6. Reimbursement Model - Europe CGM (Continuous Glucose Monitoring)

7. Abbott Freestyle Libre vs CGM (Continuous Glucose Monitoring)

8. United Kingdom - Diabetes Population (2010 - 2024)

9. United Kingdom - CGM Market & Forecast

10. United Kingdom - CGM User (2010 - 2024)

11. CGM Reimbursement in United Kingdom

12. Germany - Diabetes Population (2010 - 2024)

13. Germany - CGM Market & Forecast

14. Germany - CGM User (2010 - 2024)

15. CGM Reimbursement in Germany

16. Netherlands - Diabetes Population (2010 - 2024)

17. Netherlands - CGM Market & Forecast

18. Netherlands - CGM User (2010 - 2024)

19. CGM Reimbursement in Netherlands

20. Sweden - Diabetes Population (2010 - 2024)

21. Sweden - CGM Market & Forecast

22. Sweden - CGM User (2010 - 2024)

23. CGM Reimbursement in Sweden

ADVERTISEMENT

24. France - Diabetes Population (2010 - 2024)

25. France - CGM Market & Forecast

26. France - CGM User (2010 - 2024)

27. CGM Reimbursement in France

28. Switzerland - Diabetes Population (2010 - 2024)

29. Switzerland - CGM Market & Forecast

30. Switzerland - CGM User (2010 - 2024)

31. CGM Reimbursement in Switzerland

32. Growth Drivers

33. Challenges

For more information about this report visit https://www.researchandmarkets.com/research/qppzmg/the_cgm_market_in?w=4

View source version on businesswire.com:https://www.businesswire.com/news/home/20180716005607/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Glucose Testing,Diabetes Devices,Wearable Technology

KEYWORD: EUROPE

INDUSTRY KEYWORD: HEALTH MEDICAL DEVICES DIABETES

SOURCE: Research and Markets

Copyright Business Wire 2018.

PUB: 07/16/2018 12:18 PM/DISC: 07/16/2018 12:18 PM

http://www.businesswire.com/news/home/20180716005607/en